Skip to main content
JSW Dulux Limited logo

JSW Dulux Limited — Investor Relations & Filings

Ticker · JSWDULUX ISIN · INE133A01011 BSE.NS Manufacturing
Open in API
Filings indexed 2,253 across all filing types
Latest filing 2025-05-02 Regulatory Filings
Country IN India
Listing BSE.NS JSWDULUX

About JSW Dulux Limited

https://www.jswpaints.in/

JSW Dulux Limited specializes in the development, manufacture, and distribution of a comprehensive range of decorative and industrial coating solutions. The company’s portfolio includes interior and exterior emulsions, protective finishes, enamels, and specialized wood coatings designed for both residential and commercial applications. Utilizing advanced chemical formulations, the organization focuses on delivering high-performance products characterized by durability, color precision, and environmental sustainability. Key offerings feature low-VOC compositions, weather-resistant technologies, and anti-microbial properties. The company serves a broad market spectrum, providing technical coating systems for infrastructure projects alongside consumer-grade paints. Its operations emphasize innovation in surface protection and aesthetic enhancement through rigorous research and development.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a notice from Akzo Nobel India Limited informing the stock exchanges about a scheduled Board of Directors meeting on 14th May 2025. The agenda includes consideration and approval of audited standalone and consolidated financial results for the quarter and financial year ended 31st March 2025, and recommendation of final dividend for the financial year 2024-25. The document is a notification of an upcoming board meeting and does not contain the actual financial results or detailed report. It is also relatively short (1867 characters). Therefore, it is an announcement related to board meeting and financial results approval, not the financial report itself. According to the filing definitions and rules, this fits best under Regulatory Filings (RNS) as a general regulatory announcement and notification of board meeting and agenda.
2025-05-02 English
Akzo Nobel India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve audited financial results ....
Regulatory Filings Classification · 95% confidence The document is a notice from Akzo Nobel India Limited informing the stock exchanges about an upcoming Board of Directors meeting scheduled for May 14, 2025. The agenda includes consideration and approval of audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2025, and recommendation of final dividend for the financial year 2024-25. The document is a notification of a board meeting and does not contain the actual financial results or detailed report. It is also short (1867 characters) and serves as an announcement rather than the report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about a board meeting and upcoming financial results approval, not the financial report or dividend notice itself.
2025-05-02 English
Outcome of Board Meeting
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from Akzo Nobel India Limited regarding the outcome of a Board Meeting held on April 30, 2025. It discusses an extension request related to previously disclosed proposed transactions involving the sale of business units and intellectual property. The document references prior disclosures, shareholder approvals via postal ballot, and the Board's decision to grant an extension for executing definitive agreements. There are no financial statements, detailed financial analysis, or comprehensive report content. The document serves as a regulatory update on corporate actions and board decisions, consistent with a Capital/Financing Update or transaction progress announcement. Given the focus on transaction updates and board meeting outcomes related to financing and business restructuring, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2025-04-30 English
Please find attached outcome of board meeting held today, 30th April 2025
Regulatory Filings Classification · 95% confidence The document is a formal announcement from Akzo Nobel India Limited regarding the outcome of a Board Meeting held on 30th April 2025. It discusses an extension request related to previously disclosed proposed transactions involving the sale of business units and intellectual property. The document references prior disclosures, shareholder approvals via postal ballot, and the Board's decision to grant an extension for executing definitive agreements. There are no financial statements, detailed financial analysis, or comprehensive report content. The document serves as a regulatory update on corporate actions and board decisions, fitting the category of a Regulatory Filing (RNS) under SEBI regulations. It is not a full report, audit, earnings release, or presentation, but a formal disclosure of board meeting outcomes and transaction status.
2025-04-30 English
Updates
Regulatory Filings Classification · 95% confidence The document is a detailed policy/code of conduct for prohibition of insider trading by Akzo Nobel India Limited. It includes definitions, regulatory references to SEBI (Securities and Exchange Board of India) regulations, and internal compliance procedures. The document is not a financial report, earnings release, or management discussion. It is a regulatory compliance document related to insider trading policies, which is a regulatory filing. It is not an announcement of a report but the actual policy document itself. Therefore, it fits best under Regulatory Filings (RNS). The document length (15,000 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2025-04-17 English
Please find attached the amended Policy/Code for Prohibition of Insider trading for the company.
Regulatory Filings Classification · 95% confidence The document is a detailed policy/code of conduct for prohibition of insider trading by Akzo Nobel India Limited. It includes definitions, regulatory references to SEBI (Securities and Exchange Board of India) regulations, and outlines compliance requirements and procedures related to insider trading. It is not a financial report, earnings release, or management discussion. It is a regulatory compliance document related to governance and internal controls. The document is not a brief announcement or a certification but a full policy document. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance documents and miscellaneous regulatory filings that do not fit other categories.
2025-04-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.